佰金生命科学(01466)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01466 佰金生命科学

交易中 05-12 13:09:50

0.510

-0.030

-5.56%

最高0.520	最低0.510	成交量26.40万
今开0.520	昨收0.540	日振幅1.85%
总市值4.75亿	流通市值4.75亿	总股本9.32亿
成交额13.67万	换手率0.03%	流通股本9.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01466","market":"HK","secType":"STK","nameCN":"佰金生命科学","latestPrice":0.51,"timestamp":1778562000067,"preClose":0.54,"halted":0,"volume":264000,"delay":0,"changeRate":-0.0555555555555556,"floatShares":932000000,"shares":932000000,"eps":-0.000455,"marketStatus":"交易中","change":-0.03,"latestTime":"05-12 13:09:50","open":0.52,"high":0.52,"low":0.51,"amount":136720,"amplitude":0.018519,"askPrice":0.52,"askSize":48000,"bidPrice":0.51,"bidSize":88000,"shortable":0,"etf":0,"ttmEps":0.009,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778573400000},"marketStatusCode":2,"adr":0,"listingDate":1413475200000,"exchange":"SEHK","adjPreClose":0.54,"openAndCloseTimeList":[[1778549400000,1778558400000],[1778562000000,1778572800000]],"volumeRatio":2.511531,"lotSize":8000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01466","defaultTab":"news","newsList":[{"id":"2633164997","title":"港股公告掘金 | 东方证券拟通过发行A股股份及支付现金方式购买上海证券100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2633164997","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633164997?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:00","pubTimestamp":1778115646,"startTime":"0","endTime":"0","summary":"重大事项：石四药集团(02005)取得甲磺酸多沙唑嗪缓释片(4mg)等药品的生产注册批件中国生物制药(01177)：库莫西利胶囊“CDK2/4/6抑制剂”一线治疗乳腺癌新适应症获批上市佰金生命科学(01466)附属与扶摇元气订立策略合作框架协议 开展临床细胞治疗领域的策略合作石四药集团(02005)：全量程C反应蛋白(hsCRP+常规CRP)检测试剂盒及血清淀粉样蛋白A/C反应蛋白(SAA/CRP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438848.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02005","BK0012","IE00BZ08YT58.USD","161027","BK1227","BK4588","399300","VXUS","IE00BZ08YR35.GBP","BK0028","BK1191","IE00BZ08YS42.EUR","BK0188","BK1515","BK1589","HK0000165453.HKD","BK0183","01177","BK4585","159982","01466","LU2460026573.USD","BK1147","BK0276","BK1521","BK1564","03958","600958"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633838071","title":"佰金生命科学(01466)附属与扶摇元气订立策略合作框架协议 开展临床细胞治疗领域的策略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2633838071","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633838071?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:24","pubTimestamp":1778059464,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学 发布公告，本公司间接全资附属公司北京佰金生物科技有限公司与扶摇元气生物科技有限公司订立策略合作框架协议，内容有关临床细胞治疗领域的策略合作。根据合作框架协议，北京佰金将负责合作范围内产品的研发、生产、质量控制及全球供应链支持，并建立统一的合规标准体系。扶摇元气亦具备临床细胞药物研究备案的经验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177155654","title":"佰金生命科学4月股份变动月报表：股本维持不变，新增授出67,925,226份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1177155654","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177155654?lang=zh_cn&edition=full","pubTime":"2026-05-05 11:06","pubTimestamp":1777950367,"startTime":"0","endTime":"0","summary":"佰金生命科学控股有限公司于2026年5月5日公布截至2026年4月30日的证券变动月报情况。报告期内，佰金生命科学并未进行新增股份发行或购回注销活动。关于股权激励方面，依据公司于2024年9月30日采纳的购股权计划，公司在4月期间授出67,925,226份购股权。截至4月底，该购股权计划下本月底结存的有效股份期权同为67,925,226份，本月并未因此实际发行新的普通股或转让库存股份。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01466"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629817363","title":"佰金生命科学(01466)合共授出6792.52万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2629817363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629817363?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:09","pubTimestamp":1777025346,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，根据其于2024年9月30日采纳的购股权计划，公司于2026年4月24日向合资格参与者合共授出6792.52万份购股权，以认购公司股本中每股股份0.02港元之普通股，须待承授人接纳购股权后，方可作实。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141436933","title":"佰金生命科学2026年3月股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1141436933","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141436933?lang=zh_cn&edition=full","pubTime":"2026-04-01 11:31","pubTimestamp":1775014302,"startTime":"0","endTime":"0","summary":"佰金生命科学控股有限公司于2026年4月1日发布月报表，报告期为2026年3月。公司本期普通股及注册股本无新增发行、购回或注销事项，股本状况整体保持不变。公司披露，截至2026年3月31日，法定及注册股本均维持在10,000,000,000股，对应注册股本总额港币200,000,000元。期末已发行普通股为932,254,085股，与上月底一致，库存股持续为零。公司声明，所有证券发行及股份相关事项均符合法律法规及上市规则规定。公告由董事张诗敏签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01466"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120754262","title":"佰金生命科学控股（01466）2026年2月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1120754262","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120754262?lang=zh_cn&edition=full","pubTime":"2026-03-04 10:50","pubTimestamp":1772592659,"startTime":"0","endTime":"0","summary":"佰金生命科学控股有限公司（01466）于2026年3月4日发布截至2026年2月28日的月报表。公告显示，公司法定/注册股本仍为10,000,000,000股，面值每股0.02港元，总额维持在200,000,000港元，与上月保持一致。\n截至本月末，公司已发行普通股数量为932,254,085股，较上月无新增发行、无回购或注销记录。本月亦无股份期权、权证及可换股票据的变动事项。公司确认其已遵守上市规则及适用法律法规的要求。\n公告由董事张诗敏签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01466"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616671387","title":"佰金生命科学(01466)：沈定获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2616671387","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616671387?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:32","pubTimestamp":1772443954,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，沈定女士已获委任为公司独立非执行董事以及公司审核委员会、薪酬委员会及提名委员会成员，自2026年3月2日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606020036","title":"佰金生命科学(01466)：独立非执行董事黄兆强获委任为审核委员会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2606020036","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606020036?lang=zh_cn&edition=full","pubTime":"2026-01-27 18:00","pubTimestamp":1769508039,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，李家梁先生由于彼个人原因，故已辞任独立非执行董事，并不再担任本公司审核委员会主席以及薪酬委员会及提名委员会各自的成员，自2026年1月27日起生效。董事会宣布，继李先生辞任后，独立非执行董事黄兆强先生已获委任为审核委员会主席，自2026年1月27日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595678437","title":"佰金生命-八千12月29日主力净流入34.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2595678437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595678437?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:15","pubTimestamp":1766996120,"startTime":"0","endTime":"0","summary":"12月29日，佰金生命-八千股价收平报0.52元，成交金额40.3万元，换手率0.08%，振幅6.73%，量比2.73。佰金生命-八千今日主力资金净流入34.3万元，上一交易日主力净流出0万元。该股近5个交易日上涨4.00%，主力资金累计净流入34.3万元；近20日主力资金累计净流入34.3万元，其中净流入天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161619a48534ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161619a48534ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588728206","title":"佰金生命科学(01466)附属与谷环医疗签订策略合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2588728206","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588728206?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:13","pubTimestamp":1764580437,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学 发布公告，公司间接全资附属公司北京佰金生物科技有限公司与上海谷环医疗器械有限公司签订策略合作框架协议，据此，北京佰金将透过认购股权的方式对谷环医疗进行投资，旨在构建集团品牌医疗产品直营门店销售渠道。同时，将会拟任命梁亮先生为集团医疗事业部总监，负责医疗产品拓展工作。合作框架协议将于2026年12月31日届满，协议任何一方均可提前 10天通知另一方提前终止合作框架协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159891","01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588748626","title":"佰金生命科学(01466)根据一般授权发行4000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588748626","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588748626?lang=zh_cn&edition=full","pubTime":"2025-12-01 11:44","pubTimestamp":1764560696,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，于2025年11月28日根据公司股东于2024年9月30日批准的一般授权发行4000万股新股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1227","01466"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586244873","title":"佰金生命科学(01466)公布中期业绩 拥有人应占溢利217.3万港元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2586244873","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586244873?lang=zh_cn&edition=full","pubTime":"2025-11-27 18:48","pubTimestamp":1764240519,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)公布截至2025年9月30日止六个月的中期业绩，收入为5514.5万港元，同比减少22.22%;公司拥有人应占溢利217.3万港元，同比扭亏为盈;每股盈利0.28港仙。公告称，扭亏为盈主要由于可换股债券的公平值变动收益及毛利的减幅被抵销所致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1227","01466"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161104659","title":"佰金生命科学2025年中期财报：净利润250万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161104659","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161104659?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:38","pubTimestamp":1764059884,"startTime":"0","endTime":"0","summary":"本季度信息\n佰金生命科学控股有限公司（股份代号：1466）公告，截至2025年9月30日止六个月，公司经调整后净利润约为250万港元，而去年同期（截至2024年9月30日止六个月）净亏损约190万港元，实现同比扭亏为盈。公告显示，此次净利润增长主要由于可换股债券公平值变动带来的收益，同时受到毛利减少部分的抵销影响。公司计划于2025年11月27日正式公布中期业绩，相关数据仍待最终审阅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01466"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586134428","title":"佰金生命科学(01466)发盈喜 预计中期纯利约250万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586134428","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586134428?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:36","pubTimestamp":1764059761,"startTime":"0","endTime":"0","summary":"佰金生命科学(01466)发布公告，集团预期截至2025年9月30日止六个月将取得...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584891934","title":"佰金生命科学(01466)附属拟入股投资优环生物 打造全球领先的环状RNA(circ RNA)技术研发平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2584891934","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584891934?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:36","pubTimestamp":1763541371,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学 公布，公司间接全资附属公司北京佰金生物科技有限公司与优环(苏州)生物医药科技有限公司签订策略合作框架协议，据此，北京佰金将透过认购优环生物股权的方式对优环生物进行投资，旨在打造全球领先的环状RNA技术研发平台并借助此平台，深化细胞治疗领域的技术创新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0009354923.USD","BK4139","BK4585","RNA","01466","BK1227","BK4588","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584667755","title":"佰金生命科学11月27日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2584667755","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584667755?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:39","pubTimestamp":1763368797,"startTime":"0","endTime":"0","summary":"格隆汇11月17日丨佰金生命科学(01466.HK)宣布，公司将于2025年11月27日(星期四)举行董事会会议，藉以(其中包括)批准公司及其附属公司截至2025年9月30日止六个月的未经审核中期业绩公告，以及考虑派付中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117164012a4a731a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117164012a4a731a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512148178","title":"佰金生命科学盘中异动 早盘股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512148178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512148178?lang=zh_cn&edition=full","pubTime":"2025-02-19 09:30","pubTimestamp":1739928654,"startTime":"0","endTime":"0","summary":"2025年02月19日早盘09时30分，佰金生命科学股票出现异动，股价急速上涨6.00%。佰金生命科学股票所在的其他零售商行业中，整体涨幅为0.00%。其相关个股中，佰金生命科学、六福集团、弥明生活百货涨幅较大，振幅较大的相关个股有周大福、马可数字科技、上美股份，振幅分别为1.14%、0.85%、0.68%。佰金生命科学公司简介：钱唐控股有限公司是一家主要从事采购、加工、设计、生产及批发分销珍珠及珠宝产品的中国香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021909305496281206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021909305496281206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1227","01466"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511590897","title":"佰金生命科学盘中异动 临近收盘股价大涨8.16%报0.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511590897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511590897?lang=zh_cn&edition=full","pubTime":"2025-02-13 15:45","pubTimestamp":1739432753,"startTime":"0","endTime":"0","summary":"2025年02月13日临近收盘15时45分，佰金生命科学股票出现波动，股价大幅拉升8.16%。截至发稿，该股报0.530港元/股，成交量8万股，换手率0.01%，振幅9.18%。资金方面，该股资金流入1.696万港元，流出1.552万港元。佰金生命科学股票所在的其他零售商行业中，整体跌幅为0.46%。其相关个股中，修身堂、亨得利、梦金园涨幅较大，振幅较大的相关个股有修身堂、恒基发展、梦金园，振幅分别为17.72%、12.50%、7.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502131545539883c72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502131545539883c72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510840728","title":"佰金生命科学盘中异动 早盘股价大跌7.41%报0.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510840728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510840728?lang=zh_cn&edition=full","pubTime":"2025-02-11 11:26","pubTimestamp":1739244366,"startTime":"0","endTime":"0","summary":"2025年02月11日早盘11时26分，佰金生命科学股票出现异动，股价大幅下挫7.41%。截至发稿，该股报0.500港元/股，成交量6.4万股，换手率0.01%，振幅1.85%。资金方面，该股资金流入0港元，流出3.232万港元。佰金生命科学股票所在的其他零售商行业中，整体跌幅为0.20%。佰金生命科学公司简介：钱唐控股有限公司是一家主要从事采购、加工、设计、生产及批发分销珍珠及珠宝产品的中国香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021111260698812495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021111260698812495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510005845","title":"佰金生命科学盘中异动 早盘股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510005845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510005845?lang=zh_cn&edition=full","pubTime":"2025-02-10 10:46","pubTimestamp":1739155594,"startTime":"0","endTime":"0","summary":"2025年02月10日早盘10时46分，佰金生命科学股票出现波动，股价快速上涨5.77%。佰金生命科学股票所在的其他零售商行业中，整体跌幅为0.52%。其相关个股中，佰金生命科学、谢瑞麟、东方表行集团涨幅较大，振幅较大的相关个股有谢瑞麟、梦金园、金猫银猫，振幅分别为7.81%、3.91%、3.75%。佰金生命科学公司简介：钱唐控股有限公司是一家主要从事采购、加工、设计、生产及批发分销珍珠及珠宝产品的中国香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210104634961d5d1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210104634961d5d1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01466","BK1227"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mansangjewellery.com","stockEarnings":[{"period":"1week","weight":0.0189},{"period":"1month","weight":-0.1148},{"period":"3month","weight":0},{"period":"6month","weight":-0.0847},{"period":"1year","weight":-0.2394},{"period":"ytd","weight":0.0588}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0198},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.0192},{"period":"1year","weight":0.1548},{"period":"ytd","weight":0.0303}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"佰金生命科学控股有限公司（原名：钱唐控股有限公司）是一间主要从事制造及销售珠宝产品的投资控股公司。该公司通过五个分部运营业务。销售珍珠及珠宝产品分部从事设计及销售珠宝产品以及销售珍珠。品牌营销及咨询服务分部从事按照合约协定的服务条款提供品牌营销及咨询服务。护肤解决方案业务分部从事以品牌FO名称， 透过销售合约向化妆店及医院出售护肤解决方案产品，并透过网上销售平台向个别客户出售护肤解决方案产品。研发服务分部从事提供专业科研服务。策略投资及财务服务分部从事房地产金融资产投资。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.007696},{"month":2,"riseRate":0.333333,"avgChangeRate":0.005002},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.026403},{"month":4,"riseRate":0.5,"avgChangeRate":0.005266},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.014701},{"month":6,"riseRate":0.272727,"avgChangeRate":0.078182},{"month":7,"riseRate":0.777778,"avgChangeRate":0.168644},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.066372},{"month":9,"riseRate":0.727273,"avgChangeRate":-0.001996},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.032601},{"month":11,"riseRate":0.5,"avgChangeRate":0.074628},{"month":12,"riseRate":0.25,"avgChangeRate":-0.004674}],"exchange":"SEHK","name":"佰金生命科学","nameEN":"BAIJIN LIFE SCI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"佰金生命科学(01466)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供佰金生命科学(01466)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"佰金生命科学,01466,佰金生命科学股票,佰金生命科学股票老虎,佰金生命科学股票老虎国际,佰金生命科学行情,佰金生命科学股票行情,佰金生命科学股价,佰金生命科学股市,佰金生命科学股票价格,佰金生命科学股票交易,佰金生命科学股票购买,佰金生命科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"佰金生命科学(01466)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供佰金生命科学(01466)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}